CoChat

Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity

Open access
Charlson, Mary, Charlson, Robert E., Briggs, William, Hollenberg, James · 2007 · Journal of General Internal Medicine
Cited by 99

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

ContextDisease management programs are increasingly used to manage costs of patients with chronic disease.ObjectiveWe sought to examine the clinical characteristics and measure the health care expenditures of patients most likely to be targeted by disease management programs.DesignRetrospective analysis of prospectively obtained data.SettingA general medicine practice with both faculty and residents at an urban academic medical center.ParticipantsFive thousand eight hundred sixty-one patients enrolled in the practice for at least 1 year.Main OutcomesAnnual cost of diseases targeted by disease management.MeasurementsPatients’ clinical and demographic information were collected from a computer system used to manage patients. Data included diagnostic information, medications, and resource usage over 1 year. We looked at 10 common diseases targeted by disease management programs.ResultsUnadjusted annual median costs for chronic diseases ranged between $1,100 and $1,500. Congestive heart failure ($1,500), stroke ($1,500), diabetes ($1,500), and cancer ($1,400) were the most expensive. As comorbidity increased, annual adjusted costs increased exponentially. Those with comorbidity scores of 2 or more accounted for 26% of the population but 50% of the overall costs.ConclusionsCosts for individual chronic conditions vary within a relatively narrow range. However, the costs for patients with multiple coexisting medical conditions increase rapidly. Reducing health care costs will require focusing on patients with multiple comorbid diseases, not just single diseases. The overwhelming impact of comorbidity on costs raises significant concerns about the potential ability of disease management programs to limit the costs of care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11606-007-0130-7

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 99

Metadata

Authors
Charlson, M., Charlson, R. E., Briggs, W., & Hollenberg, J.
Venue
Journal of General Internal Medicine
Published
2007-02-03
Volume
22
Issue
4
Pages
464-469
ISSN
  • 0884-8734 (ISSN-L)
  • 1525-1497
OpenAlex
W2044328778
Cited by
99
References
5
FWCI
5.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity. https://app.cochat.ai/papers/10.1007/s11606-007-0130-7
The paper
Charlson, M., Charlson, R. E., Briggs, W., & Hollenberg, J. (2007). Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-007-0130-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.